期刊文献+

Study on the Early Detection and Clinico—pathologic Staging of Colorectal Cancer in China 被引量:1

我国大肠癌的早期发现和临床病理学分期研究(英文)
下载PDF
导出
摘要 Objective To confirm an effective and practicable screening model for early detection of colorectal cancer (CRC) , and to modify an acceptable and reasonable staging of CRC for predicting prognosis and to define the therapeutic strategy.Methods Data from 3 case-control studies have been used for selecting the high risk factors of CRC to optimize Sequencing Screening Model (SSM) . The fieldwork recalls have been utilized to compare the sensitivity, specificity and Youden Index between the SSM and the optimized one. The 1722 individuals have been used to evaluate the Optimized Sequencing Screening Model (OPSM). From 1980 to 1995, 1334 cases of CRC pathologically confirmed have been analyzed for 3-, 5- and 10-year survival rates. All tests were performed at the 0.05 level of significances. Statistical analysis was conducted by using the SPSS 10.0 statistic software.Results A simple questionnaire and RPHA-FOB test as the screening model for early detecting CRC had been proved as an optimized screening model. The sensitivity, specificity and Youden Index of the optimized model were higher than those of SSM. From the 1722 individuals 4 Dukes A and 5 Dukes B CRC were screened out. Analysis of the 3-, 5- and 10-year survival rates revealed that there were statistically significant differences between serosa and extraserosa. The 3-, 5- and 10-year survival rates were 0.91?
出处 《The Chinese-German Journal of Clinical Oncology》 CAS 2002年第2期68-71,共4页 中德临床肿瘤学杂志(英文版)
关键词 colorectal cancer early detection clinico-pathologic staging 中国 结直肠癌 早期发现 早期检测 临床病理分期 大肠癌
  • 相关文献

参考文献15

  • 1Bachar-Lustig E, Rachamim N, Li HW,et al. Megadose of T cell-depleted bone marrow overcomes MHC barriers in subletballyirradiated mice. Nat Med, 1995,1(12):1268-1273.
  • 2Bensinger WI, Buckner CD, Anasetti C,et al. Allogeneic marrow transplantation formultiple mycloma:an analysis of risk factors on outcome. Blood, 1996,88(7):2787-2793.
  • 3Bjorkstrand BB, Ljungman P, Svensson H, et al. Allogeneic bone marrowtransplantation versus autologous stem cell transplantation in multiple myeloma: aretrospective casc-matched study from the European Group for Blood and MarrowTransplantation. Blood, 1996,88(12):4711-4718.
  • 4Fuchimoto Y, Huang CA, Yamada K, et al. Mixed chimcrism and tolerance without wholebody irradiation in a large animal model. J Clin Invest,2000,105(12):1779-1789.
  • 5Gahrton G, Tura S, Ljungman P,et al. An update of prognostic factors for allogeneicbone marrow transplantation in multiple myeloma using matched sibling donors. EuropeanGroup for Blood and Marrow Transplantation. Stem Cells, 1995,13 Suppl 2:122-125.
  • 6Garban F, Attal M, Rossi JF, et al. Immunotherapy by non-myeloablative allogeneicstem cell transplantation in multiple mycloma:results of a pilot study as salvage therapyafter autologous transplantation. Leukemia, 2001,15(4):642-646.
  • 7Giralt S, Estey E, Albitar M, et al. Engraftment of allogeneic hematopoieticprogenitor cells with purine analog-containing chemotherapy: harnessinggraft-versus-leukemia without myeloablative therapy. Blood, 1997,89(12):4531-4536.
  • 8Giralt S, Khouri I, Champlin R. Non myeloablative "mini transplants".Cancer Treat Res, 1999,101:97-108.
  • 9Goerner M, et al. Allogeneic transplantation after lymphoablative conditioning inmultiple myeloma. Bone Marrow Transplant, 2001, 27 Suppl 2:247.
  • 10Porter DL, Luger SM, Duffy KM, et al. Allogeneic cell therapy for patients whorelapse after autologous stem ccll transplantation. Biol Blood Marrow Transplant,2001,7(4):230-238.

同被引文献11

  • 1师英强,宗祥云,王亚农,莫善兢.结直肠高级别上皮内瘤变的临床意义及外科治疗(附83例报告)[J].中国癌症杂志,2004,14(5):406-409. 被引量:24
  • 2中国大肠癌病理与预后协作组.大肠癌Dukes'分期的预后分析[J].中华肿瘤杂志,1986,8(2):144-145.
  • 3Carreras F,Sarli L,Pietra N,et al.A critical review of the history of the systems for staging colorectal cancer [J].G Chir,1992,13(5):287-292.
  • 4Greene FL,page DL,Fleming ID,et al.AJCC cancer staging manual 6th ed[M].New York,NY:Springer,2002.215-246.
  • 5Sobin LH,Wittekind C.TNM:Classification of malignant tumours[M].6th ed.New York,NY:Wiley-Liss,2002.55-87.
  • 6Carolyn C,Compton MD,Frederick L,et al.The staging fo colorectal cancer:2004 and beyond [J].CA Cancer J Clin,2004,54(6):295-308.
  • 7Greene FL,Stewart AK,Norton HJ.A new TNM staging strategy for node-positive (Stage Ⅲ)colon cancer:an analysi of 50 042 patients [J].Ann Surg,2002,236(4):416-421.
  • 8Goldstein NS.Lymph node recoveries from 2427 pT3 colorectal resection specimens spanning 45 years:recommendations for a minimum number of recovered lymph nodes based on predictive probabilities [J].Am J Surg Pathol,2002,26(2):179-189.
  • 9Wilcox GM,Anderson PB,Colacchio TA.Early invasive carcinoma in colonic polyps:areview of the literature with emphasis on the assessment of the risk of metastasis [J].Cancer,1986,57(1):160-171.
  • 10Cooper HS,Deppish LM,Gourley WK,et al.Endoscopically removed malignant colorectal polyps: clinicopathologic correlations [J].Gastroenterology,1995,108(6):1657-1665.

引证文献1

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部